We are live on ! Find out more
CAM

Connacht Asset Management Portfolio holdings

AUM $16.9M
1-Year Est. Return 40.41%
This Fund
S&P 500
This Quarter Est. Return
-2.37%
1 Year Est. Return
+40.41%
3 Year Est. Return
+63.75%
5 Year Est. Return
10 Year Est. Return
AUM
$195M
AUM Growth
+$92.8M
Cap. Flow
-$13.7M
Cap. Flow %
-7.03%
Top 10 Hldgs %
45.56%
Holding
153
New
58
Increased
27
Reduced
36
Closed
31

Sector Composition

Rank Sector Weight
1 Miscellaneous 66.26%
2 Technology 6.85%
3 Healthcare 6.81%
4 Consumer Discretionary 6.15%
5 Energy 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FORM icon
101
FormFactor
FORM
$8.61B
$386K 0.2%
9,174
-931
-9% -$38.8K
QTWO icon
102
Q2 Holdings
QTWO
$4.1B
$386K 0.2%
6,255
-1,437
-19% -$92.1K
OZK icon
103
Bank OZK
OZK
$5.39B
$351K 0.18%
8,222
-3,786
-32% -$177K
TWNK
104
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$345K 0.18%
+15,719
New +$326K
MRVI icon
105
Maravai LifeSciences
MRVI
$1.25B
$342K 0.18%
9,695
-6,856
-41% -$230K
GBCI icon
106
Glacier Bancorp
GBCI
$6.16B
$313K 0.16%
+6,217
New +$336K
IBTX
107
DELISTED
Independent Bank Group, Inc.
IBTX
$311K 0.16%
4,371
-2,020
-32% -$154K
NCLH icon
108
Norwegian Cruise Line
NCLH
$7.65B
$305K 0.16%
+13,951
New +$285K
AGIO icon
109
Agios Pharmaceuticals
AGIO
$2.05B
$281K 0.14%
9,648
+2,515
+35% +$76.8K
EEFT icon
110
Euronet Worldwide
EEFT
$2.56B
$278K 0.14%
2,138
-15,161
-88% -$1.92M
INBX
111
DELISTED
Inhibrx, Inc. Common Stock
INBX
$275K 0.14%
12,361
+5,266
+74% +$134K
ALXO icon
112
ALX Oncology
ALXO
$283M
$273K 0.14%
16,165
+5,841
+57% +$99.7K
NSTG
113
DELISTED
NanoString Technologies, Inc.
NSTG
$273K 0.14%
7,853
-30,936
-80% -$1.07M
MRTX
114
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$273K 0.14%
3,318
-3,138
-49% -$321K
CYTK icon
115
Cytokinetics
CYTK
$10.8B
$272K 0.14%
7,390
-4,627
-39% -$164K
LASR icon
116
nLIGHT
LASR
$2.6B
$247K 0.13%
14,272
-4,003
-22% -$75.3K
CRMT icon
117
PUT
America's Car Mart
CRMT
$20M
$201K 0.1%
+2,500
New +$237K
SEEL
118
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$194K 0.1%
60
-70
-54% -$301K
KPLT icon
119
Katapult Holdings
KPLT
$480M
$189K 0.1%
3,170
-26,416
-89% -$1.56M
SLGC
120
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$170K 0.09%
+21,253
New +$187K
GOCO
121
CALL
DELISTED
GoHealth
GOCO
$75K 0.04%
+4,213
New +$131K
KPLTW
122
DELISTED
Katapult Holdings Warrant
KPLTW
$21K 0.01%
64,928
AGYS icon
123
Agilysys
AGYS
$3.4B
-8,103
Closed -$360K
AIP icon
124
Arteris
AIP
$1.16B
-15,042
Closed -$318K
BMRN icon
125
BioMarin Pharmaceuticals
BMRN
$12.6B
-4,069
Closed -$359K

Similar funds

Connacht Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Connacht Asset Management held 153 positions worth $195M, up 91% from $103M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Connacht Asset Management withdrew a net $13.7M in Q1 2022, closing 31 positions and reducing 36 holdings. Its most notable exit was Opendoor, an estimated $2.5M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 66% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Connacht Asset Management opened a new position in Customers Bancorp worth $1.28M.

  • Connacht Asset Management's largest Q1 2022 buy was Customers Bancorp: 24,647 shares worth $1.28M.
  • Connacht Asset Management added most to Cerence in Q1 2022, an estimated $1.47M increase.
  • Connacht Asset Management's biggest Q1 2022 reduction was Euronet Worldwide, cutting an estimated $1.92M.
  • Connacht Asset Management fully exited Opendoor in Q1 2022, selling an estimated $2.5M.
  • Connacht Asset Management's ten largest holdings make up 46% of its $195M portfolio in Q1 2022.
  • Connacht Asset Management opened 58 new positions and closed 31 in Q1 2022.
  • Connacht Asset Management's portfolio value rose 91% quarter-over-quarter to $195M.

Based on Connacht Asset Management's 13F filing for Q1 2022, filed 16 May 2022.